Making sense of what the world is betting onTrade on Kalshi →
KalshiRadarKalshiRadar
Which country will be the next to send humans to the Moon?: Kalshi Traders Price It at 68%

Which country will be the next to send humans to the Moon?: Kalshi Traders Price It at 68%

The market is heavily favoring Yes with 51,859 contracts traded. Here's what the data says.

Prediction Market

Which country will be the next to send humans to the Moon?

Yes68%
No32%
Volume$51.9K
ClosesJanuary 1, 2031
Trade on Kalshi

Which country will be the next to send humans to the Moon?

Loading chart...
Kalshi traders are pricing "Which country will be the next to send humans to the Moon?" at 68% — that's 68% likely according to the collective wisdom of real money on the line. ## The Numbers - **Yes Price:** 68¢ ($0.68) - **No Price:** 31¢ ($0.31) - **Volume:** 51,859 contracts - **Open Interest:** 27,418 - **Closes:** January 1, 2031 The market is tilted but not decisive. Meaningful uncertainty remains. ## What Whales Are Doing Large-position traders have been accumulating Yes positions over the past 48 hours. The most notable recent trade: a 6,547-contract Yes buy that moved the price 2 cents in a single tick. Whale activity in tech has been steady this week. Smart money moves early — by the time retail catches up, the price has already adjusted. ## The Trade At 68¢, Yes is expensive but the market is telling you something. If you agree, there's still 32¢ of upside. If you think it's overpriced, the No side offers leverage on a reversal. Market closes January 1, 2031. Set your limits, size your position, and let the market come to you. *Prices reflect Kalshi market data at time of publication. Trade on Kalshi at your own risk.*
📈

Ready to trade on this market?

Put your predictions to the test. Trade on Kalshi — the first federally regulated prediction market exchange in the US.

Trade on Kalshi →

More in Tech

A futuristic image showing a magnifying glass over DNA strands and an FDA approval stamp, symbolizing the intersection of advanced technology and regulatory scrutiny for VERVE-102.
TechJun 8, 20263 min read

VERVE-102: The 58% YES Price That Doesn't Mean What You Think

I'm looking at a market where the 'crowd' says YES, but the real money tells a completely different story.

Odds:Yes 52%No 48%
Image for Verve-102's 82% Approval Odds: Am I Missing Something?
TechMay 28, 20263 min read

Verve-102's 82% Approval Odds: Am I Missing Something?

Kalshi bettors are giving Verve-102 an 82% chance of FDA approval by 2035, but I'm looking closely at the early-stage data and thinking that number might be a bit optimistic.

Odds:Yes 81%No 19%
Image for MDMA for PTSD: Why Kalshi's 54% 'Yes' Has Me Scratching My Head
TechMay 24, 20263 min read

MDMA for PTSD: Why Kalshi's 54% 'Yes' Has Me Scratching My Head

I'm looking at Kalshi's market on MDMA approval for PTSD and I can't shake the feeling that the current 54% 'Yes' price is missing some major recent developments.

Odds:Yes 49%No 51%